CD8A and breast cancer: Higher mRNA LSR expression has been related to poor survival compared with low mRNA LSR expression in patients with subtype luminal A, B, and basal-like BC, and in the METABRIC cohort [40], and plays a negatively regulating tumor immunity role by inhibiting CD8+ T cells [41].